FDA announces steps to expedite device reviews

Share this content:
The Food and Drug Administration is taking steps to streamline medical device reviews. The agency plans to impose more than two dozen changes to its approval process. The new steps will lead to “a smarter medical device program that supports innovation, keeps jobs here at home, and brings important, safe and effective technologies to patients quickly,” said Dr. Jeffrey Shuren, director of the FDA's Center for Devices and Radiological Health. Vendors said that lower-risk devices would likely benefit most from the expedited reviews.